Results about: Alzheimer

Our research focuses on three angles of peptide and protein chemistry : the design, synthesis and structure of bioactive molecules. From a structural perspective, we apply modern NMR techniques to study complex molecular recognition processes.

Patrick Aloy: “The whole is more than the sum of its parts”

The “Meet Our Scientists” video “Networks of life” explains his work and reveals the personal side of this scientist.

Jens Lüders: “Curiosity should fuel research”

The Meet Our Scientists video series introduces Jens Lüders, who studies microtubules—mini-filaments involved in multiple cell processes. The alteration of these structures is associated with diseases such as cancer and Alzheimer’s and with developmental defects.

In the video “Curiosity as a fuel”, Lüders recalls that transcendental discoveries arise from basic research and that such science is driven exclusively by curiosity, without specifically pursuing its applicability or transfer.

Researchers discover the hidden potential of disordered proteins

The finding paves the way for the identification of new therapeutic targets for many diseases.

Discovery of molecular protection linked to a degenerative neuromuscular disease

Kennedy’s disease leads to progressive muscle wastage. It is a condition that affects only men and it appears between 40 and 50 years of age. There is no specific treatment available.

In individuals with this disease, muscle cells and motor neurons die over the years because they accumulate a protein that is mutated.

Researchers at IRB Barcelona discover that this protein has a self-protective mechanism through which the deleterious effects of the mutation are delayed.

IRB Barcelona's dancing scientists receive double honours at Spain's National Fundraising Prizes 2015

The music video, seen by more than one million viewers, has received the Best Fundraising Campaign award as well as the Jury's Grand Prize by the Spanish Association of Fundraising.

IRB Barcelona launches a new project to fight Alzheimer’s disease

The project, led by Natàlia Carulla, has been awarded funds from “La Marató de TV3” initiative held in 2013.

The project, which will be undertaken over three years, aims to verify a new therapeutic target to fight Alzheimer’s.